|Articles|February 8, 2018

How Will Corporate America's Latest "Solution" to the Health Care Cost Crisis Affect Patient Outcomes: Public Health Watch

The recent announcement that e-retailing giant Amazon, investment bank JP Morgan Chase, and multinational holding company Berkshire Hathaway are starting a health insurance company has incited mixed emotions among public health professionals.

For workers who already “owe their soul[s] to the company store,” the news that they may have to start paying their employers directly for health insurance probably isn’t exactly welcome.

However, the lyrics to the Tennessee Ernie Ford classic “Sixteen Tons” may need a reboot, as large corporations enter the health insurance marketplace with an eye toward controlling costs, with the future of the Affordable Care Act (ACA) up in the air and health care expenditures in the United States continuing to spiral out of control. The latest example of such efforts is the recently announced alliance between e-retailing giant Amazon, investment bank JP Morgan Chase, and multinational holding company Berkshire Hathaway.

The companies generated blaring headlines and sent insurance stock prices tumbling when they went public on January 30, 2018, with their plans to essentially start an insurance company to offer health benefits to all their employees. Presumably, benefits packages would cover all full-time employees and their families; however, to date, the 3 companies have been vague about what exactly the resulting insurance business will look like, and the type of health plans and coverage it will offer.

“Most large employers are already self-insured, [in that] they contract with an insurer to handle claims but can set their own coverage policies,” David Himmelstein, MD, Distinguished Professor, School of Urban Public Health and the Roosevelt House Public Policy Institute at Hunter College in New York, told Contagion®. “[However], a return to the old system of company doctors raises concern about to whom the doctors are accountable, and whether patients’ interests will take second place to employers’.”

According to Dr. Himmelstein, who has written extensively about health care payment models and issues related to access to care and coverage, the Amazon/Chase/Berkshire initiative is hardly the first foray by non-insurance players into the health care insurance marketplace. As NPR reminds us in its report on the news from Amazon et al, insurer Kaiser Permanente, now one of the biggest providers in the industry, started as an offshoot of the Kaiser Shipyards, owned by multimillionaire industrialist Henry J. Kaiser. Initially, it offered company employees workers compensation coverage before adding health care insurance.

More recently, companies such as Boeing, Walmart, and, as of February 1, 2018, Walt Disney have attempted to bypass the traditional insurance industry by essentially creating their own health maintenance organizations (HMOs) for employees. The Disney plan, which garnered much less attention than the Amazon/Chase/Berkshire initiative, likely because Jeff Bezos and Warren Buffett aren’t involved, will only be offered to the company’s staff in Central Florida. The Orlando Sentinel reports that Disney has contracted with the Orlando region’s 2 largest health systems, Orlando Health and Florida Hospital, to create 2 distinct and “affordably priced” health plans for employees, each limited to the respective systems’ networks of doctors, hospitals, and facilities. Employees who opt to see an out-of-network provider won’t be covered—except in “special circumstances,” the newspaper reports.

“Some large companies are already directly contracting with hospital systems, bypassing the insurance middlemen,” Dr. Himmelstein said. “[To date], none of these initiatives has had a very big effect, [and] insurers pretty much toe employers’ lines already.”

Even in its infancy, though, the effort by Amazon et al has already caused a stir, sending stock prices for major insurers as well as pharmacy benefits managers such as CVS Health and Express Scripts plummeting. Interestingly, although most industry observers agree the primary motivation is to gain some measure of control over the costs of coverage for employees’ health care, the 3 companies seem bent on portraying their initiative as altruistic, describing their insurance company as “free from profit-making incentives and constraints.” Whether that means it will be a non-profit entity remains unclear.

“Hard as it might be, reducing health care’s burden on the economy while improving outcomes for employees and their families would be worth the effort,” Bezos, Amazon’s founder and chief executive, said, per The Times.

Although Dr. Himmelstein sees “no reason to mourn for insurers” in the aftermath of the Amazon/Chase/Berkshire news, he’s hardly sanguine about the possible effects on the companies’ employees and their families either. Keep in mind, the 3 employ some 1 million workers collectively worldwide—so any impact on their workers’ health outcomes would potentially have a significant impact on public health overall.

Which makes this a story worth watching.

Brian P. Dunleavy is a medical writer and editor based in New York. His work has appeared in numerous health care-related publications. He is the former editor of Infectious Disease Special Edition.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.